Home >  News >  June, 2014

FDA Says More Decisions on Morcellation Coming

The agency will hold a public meeting in July.

Published: June 12, 2014

Will morcellation devices used to laparoscopically remove uterine fibroids be recalled or banned? The FDA is convening a meeting next month to take up the topic.

The agency issued an advisory in April, discouraging their use because the devices can spread cancerous tissue in women with undetected uterine sarcomas, a condition the agency says may affect as many as 1 in every 350 women.

However, proponents of morcellation say the proportion of women with undetected sarcomas is likely closer to 1 in 1,000; that the prognosis is already bleak for those women; and that for everyone else, the alternatives are typically much more dangerous and invasive.

The FDA's Medical Devices Advisory Committee will hold a public meeting on July 10 and 11 and plans to "make recommendations regarding the appropriate use, premarket testing, labeling, and other risk mitigations" for morcellators.

One stock analyst, Greg Chodaaczek of Sterne Agee, says the meeting is likely to result in a so-called black-box warning, saying he doesn't think there's enough data to warrant a recall or ban.

Jim Burger


Also in the News...

Joint Commission Has Zero Tolerance for Poor Hand Hygiene
Kentucky Plastic Surgeon Arrested for Allegedly Arriving at Hospital Intoxicated
Lawsuit: VA Hospital Left Scalpel Inside Army Vet's Abdomen
Single-OR Facilities Must Adhere to the Same Quality Standards as Licensed ASCs
Lawsuit: Scrub Nurse Photographed Coworker Nude in OR
Study Examines the Ergonomics of Surgery and its Adverse Effects on Physicians
Nurse Sues Prominent Ophthalmologist for Assault Over Violent Incident Caught on Security Camera

New to Outpatient Surgery Magazine?
Sign-up to continue reading this article.
Register Now
Have an account? Please log in:
Email Address:
  Remember my login on this computer

advertiser banner

Other Articles That May Interest You

Former Head of Sales Testifies NECC President Knew His Company Was to Blame for Tainted Steroids Outbreak

Ron Ronzio told jurors that as soon as they got word that a patient was ill after being injected with an NECC steroid, president Barry Cadden "knew right away it was us."

Administration Signals Likely End to Medicare Bundled Payments Initiative

Recently posted rule suggests that the twice-postponed rule will be rescinded.

Jury Clears GI Doc of Negligence in Colon Cancer Suit

A jury found David Vastola, DO, not negligent in performing a 2011 colonoscopy on a patient who 18 months later presented with terminal colon cancer.